Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Post-operative radiation therapy for advanced-stage oropharyngeal cancer.

Hansen E, Panwala K, Holland J.

J Laryngol Otol. 2002 Nov;116(11):920-4.

PMID:
12487672
2.

Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment.

Denittis AS, Machtay M, Rosenthal DI, Sanfilippo NJ, Lee JH, Goldfeder S, Chalian AA, Weinstein GS, Weber RS.

Am J Otolaryngol. 2001 Sep-Oct;22(5):329-35.

PMID:
11562884
3.

Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.

Chao KS, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, Spector GJ, Sessions DG.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):43-50.

PMID:
15093897
4.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
5.

Recurrence of oropharyngeal carcinoma after radiotherapy.

Viani L, Dammeijer P, Jones AS, Dalby JE, Stell PM.

J Laryngol Otol. 1991 Jan;105(1):24-8.

PMID:
1900317
6.

Management of stage IV glottic carcinoma: therapeutic outcomes.

Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J, Haughey BH.

Laryngoscope. 2004 Aug;114(8):1438-46.

PMID:
15280724
7.

Radiation therapy for early-stage carcinoma of the oropharynx.

Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):743-51.

PMID:
15183477
8.

Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.

Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI.

Am J Clin Oncol. 2005 Aug;28(4):385-92.

PMID:
16062081
9.

Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.

Fallai C, Bolner A, Signor M, Gava A, Franchin G, Ponticelli P, Taino R, Rossi F, Ardizzoia A, Oggionni M, Crispino S, Olmi P.

Tumori. 2006 Jan-Feb;92(1):41-54.

PMID:
16683383
10.

Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.

Lindholm P, Valavaara R, Aitasalo K, Kulmala J, Laine J, Elomaa L, Sillanmäki L, Minn H, Grénman R.

Radiother Oncol. 2006 Feb;78(2):146-51. Epub 2005 Nov 22.

PMID:
16307813
11.

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):363-73. Epub 2005 May 31.

PMID:
15925451
12.

Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.

Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE.

Head Neck. 2004 Jul;26(7):561-72.

PMID:
15229898
13.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
15.

Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.

Machtay M, Rosenthal DI, Chalian AA, Lustig R, Hershock D, Miller L, Weinstein GS, Weber RS.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):72-7.

PMID:
15093901
16.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
17.

A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.

Waldron J, Warde P, Irish J, Pintilie M, Sellmann S, Bayley A, Cummings B, Kim J, Liu FF, Payne D, Ringash J, Brown D, Freeman J, Gilbert R, Gullane P, Witterick I, O'Sullivan B.

Radiother Oncol. 2008 May;87(2):173-80. doi: 10.1016/j.radonc.2008.02.014. Epub 2008 Mar 14.

PMID:
18342965
18.
19.
20.

Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.

Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA.

J Clin Oncol. 2007 Sep 1;25(25):3971-7.

Items per page

Supplemental Content

Write to the Help Desk